|
Thursday, 31 January 2019
quote [ Secret portions of a lawsuit allege that Purdue Pharma, controlled by the Sackler family, considered capitalizing on the addiction treatment boom — while going to extreme lengths to boost sales of its controversial opioid. ]
|
rylex said @ 11:19pm GMT on 3rd February
It could be used to cover all cases.
I can cite another article comparing the effectiveness of ketaminre against oxycodone to help manage post operative pain. It showed no major difference, except ketamine was maybe safer and less addictive.
The only thing preventing its usage currently as I see it is ignorance and paychecks for docs who recommended opiates.
rylex said @ 11:19pm GMT on 3rd February
It could be used to cover all cases. Just whom do you think should be given heavy opioids and for what?
I can cite another article comparing the effectiveness of ketaminre against oxycodone to help manage post operative pain. It showed no major difference, except ketamine was maybe safer and less addictive.
The only thing preventing its usage currently as I see it is ignorance and paychecks for docs who recommended opiates.
<-- Entry / Current Comment
rylex said @ 11:19pm GMT on 3rd February
It could be used to cover all cases. Just whom do you think should be given heavy opioids and for what?
I can cite another article comparing the effectiveness of ketaminre against oxycodone to help manage post operative pain. It showed no major difference, except ketamine was maybe safer and less addictive.
The only thing preventing its usage currently as I see it is ignorance and paychecks for docs who recommended opiates.
Now it's ruled by Oxy